Effects of an Activity Control System in Patients With Diabetes: a Randomized Controlled Trial
Effects of an Activity Control System in Patients With Diabetes: a Randomized
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Antonio Luque
- Phone Number: 0034671596070
- Email: uicec@imibic.org
Study Contact Backup
- Name: PEDRO MONTAGUT MARTINEZ, nurse
- Phone Number: + (34) 630258878
- Email: pedromontagut@hotmail.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ≥ 18 years, with the ability to give informed consent
- Patient who has autonomy to carry out activities of daily living (Barthel = 100)
- patient diagnosed with Diabetes Mellitus
- patient in pharmacological treatment
- To live alone or with a person who cannot move on their own
- they do not plan to change their address in the 6 months after inclusion in the study
Exclusion Criteria:
• DM2 patients whose most recent HbA1c value is ≤7%
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Beprevent
10 will become part of the intervention group.
Each of the participants in the intervention group is selected.
At first, they are given a series of questionnaires, later (1 day later) we stay at their home to install the Beprevent device, which will remain in their home for a period of two weeks, to finish and once the device of your home, we will proceed to pass the same questionnaires as at the beginning of the test, in order to compare results.
|
10 will become part of the intervention group.
At first, they are given a series of questionnaires, later (1 day later) we stay at their home to install the Beprevent device, which will remain in their home for a period of two weeks, to finish and once the device of your home, we will proceed to pass the same questionnaires as at the beginning of the test, in order to compare results.
|
|
No Intervention: patients only evaluated
10 will be included in the control group.
During the period of the study, we will pass the same questionnaires in the participants assigned to the control group, also leaving a time interval of two weeks, and no device will be installed, nor will any monitoring be carried out in their homes.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes Knowledge Questionnaire
Time Frame: 15 minuts
|
The Diabetes Knowledge Questionnaire (DKQ-24) is a questionnaire made up of 24 questions about basic knowledge of the disease (10 items), glycemic control (7 items) and prevention of complications (7 items).
The questions are closed, with answer options "yes, no and I don't know".
Its maximum score is 24.
The patient has better knowledge about diabetes the higher the score.
|
15 minuts
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jesús Gómez Lama, MD, Maimónides Biomedical Research Institute of Córdoba
- Principal Investigator: David Pérez Cruzado, Universidad Católica San Antonio de Murcia
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- orcid.org/0000-0002-869
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.